A Search Service for Abbreviation / Long Form

■検索結果 - 略語 : RANK

検索条件

検索語：RANK

検索方法：完全一致

主な研究分野:

結果

略語: RANK

出現頻度: 1180

対応する展開形の数: 22

No.

展開形

主な研究分野

共起略語

PubMed/MEDLINE情報 (発表年, 題目)

receptor activator of NF-kappaB

(1155回)

Neoplasms

新生物, 腫瘍

(123回)

RANKL(473回)

OPG(391回)

TRAP(85回)

1998Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.

RANKL and its receptor

(3回)

Medicine

医学, 医薬

(2回)

OPG(2回)

RANKL(2回)

MSC(1回)

2016Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis.

ranked according to their competitive season performance

(2回)

Sports Medicine

スポーツ医学

(2回)

ECON(1回)

ELS(1回)

LT(1回)

2001Physiological determinants of cross-country ski racing performance.

RANKL receptor

(2回)

Science

科学

(1回)

2MD(1回)

CSF-1(1回)

CSF-1R(1回)

2012Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice.

(RANKL)-receptor-activator of nuclear kappaB

(1回)

Clinical Laboratory Techniques

臨床検査技術

(1回)

ABC(1回)

GCTB(1回)

RANKL(1回)

2014Targeting receptor-activator of nuclear kappaB ligand in aneurysmal bone cysts: verification of target and therapeutic response.

RANK ligand

(破骨細胞の分化促進因子) RANKリガンド, ランクリガンド

(1回)

Metabolism

代謝, 代謝作用, 新陳代謝, 物質代謝

(1回)

ASBMR(1回)

OPG(1回)

TNF(1回)

2000Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. The American Society for Bone and Mineral Research President's Committee on Nomenclature.

Receptors of NFkappaB

(1回)

Biochemistry

生化学, 生物化学

(1回)

BMP(1回)

TGF(1回)

TNF(1回)

2012Inhibition of osteoclast generation: a novel function of the bone morphogenetic protein 7/osteogenic protein 1.

Receptor activator of nuclear factor kappa-light-chain-enhancer of activated B-cells

(1回)

Neoplasms

新生物, 腫瘍

(1回)

TNF(1回)

2010RANK ligand: effects of inhibition.

Receptor Activator of Nuclear Transcription Factor NF-kappaB

(1回)

Biology

生物学

(1回)

OPG(1回)

2017Receptor Activator of Nuclear Transcription Factor NF-kappaB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors.

ranks based on family mean values of two traits

(1回)

Genetics

遺伝学

(1回)

BLUPs(1回)

PROB(1回)

1992Estimating the potential of sugarcane families to produce elite genotypes using bivariate prediction methods.

RANKmko

(1回)

(0回)

OPG(1回)

2016Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction.

RANKL-dependent

(1回)

Traumatology

外傷学

(1回)

M-CSF(1回)

RANKL(1回)

SAM(1回)

2006Staphylococcus aureus capsular material promotes osteoclast formation.

RANKL-suppression of its own signaling receptor

(1回)

Biology

生物学

(1回)

RANKL(1回)

2009The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse.

RANKL activity is balanced by interaction with its receptor

(1回)

Hematology

血液学

(1回)

beta-TM(1回)

DFO(1回)

EC(1回)

2010Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density.

RANKL and RANKL receptor

(1回)

Pharmacology

薬理学, 薬理, 薬品作用学

(1回)

AR(1回)

OVA(1回)

RANKL(1回)

2019An osteoclastogenesis system, the RANKL/RANK signalling pathway, contributes to aggravated allergic inflammation.

RANK-Fc

(1回)

Orthopedics

整形外科学

(1回)

OI(1回)

WT(1回)

2007The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta.

RANKL cognate receptor

(1回)

Neoplasms

新生物, 腫瘍

(1回)

OPG(1回)

TRAIL(1回)

2019Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.

RANKL interactions with its activator

(1回)

Antineoplastic Agents

抗悪性腫瘍薬

(1回)

RANKL(1回)

2008Novel anti-cancer strategy in bone tumors by targeting molecular and cellular modulators of bone resorption.

RANKL binds to its receptor

(1回)

Clinical Medicine

(1回)

NFATc1(1回)

2021A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor.

regulation of pre-osteoclasts through activation of the nuclear factor kB

(1回)

Antioxidants

(1回)

MSCs(1回)

OPG(1回)

RANKL(1回)

2020Osteoprotective Roles of Green Tea Catechins.